Results 71 to 80 of about 49,826 (161)

Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors. [PDF]

Diabetes Care, 2020
Shao H, Shi L, Fonseca VA.
europepmc   +1 more source

Multicentre quality improvement initiative to improve patient education and safety in the prescription of Sodium-Glucose transporter 2 inhibitors. [PDF]

BMJ Open Qual
Saad L, Adiga A, Anwar Mohamed M, Saha P, Kuehl M, Banerjee P, Tran P.   +6 more
europepmc   +1 more source

Sodium-glucose transporter 2 inhibitors and cardiovascular-kidney-metabolic syndrome: a narrative review. [PDF]

Front Endocrinol (Lausanne)
Wang Y, Wang Y, He X, Li X.
europepmc   +1 more source

Reduced Incidence of Aortic Dissection in Patients With Type 2 Diabetes Treated With Sodium Glucose Transporter 2 Inhibitors. [PDF]

J Am Heart Assoc
Chung CJ, Lu HY, Chung MC, Wu LY, Huo C, Kuo LK, Liu CC, Chuu CP.   +7 more
europepmc   +1 more source

Effects of different dosages of Sodium-Glucose Transporter 2 Inhibitors on lipid levels in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2020
Cai T, Gao Y, Zhang L, Yang T, Chen Q.
europepmc   +1 more source

Long-term effects of metformin versus sodium glucose transporter 2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes. [PDF]

Am J Transl Res
Hao X, Cui J, Zhang M, Zhang D.
europepmc   +1 more source

Comparative efficacy of sodium-glucose transporter 2 inhibitors on lipid profiles in nonalcoholic fatty liver disease (NAFLD): a comprehensive Bayesian network meta-analysis. [PDF]

Ann Med Surg (Lond)
Khalil I, Hossain MI, Akter M, Al-Badri SG.   +3 more
europepmc   +1 more source

Sodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes. [PDF]

Int J Mol Sci
Piccirillo F, Lanciotti M, Nusca A, Frau L, Spanò A, Liporace P, Ussia GP, Grigioni F.   +7 more
europepmc   +1 more source

Effectiveness of Sodium-Glucose Transporter 2 Inhibitors and Semaglutide on Body Composition in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Real-World Cohort Study with Bioelectrical Impedance Analysis. [PDF]

Diabetes Metab Syndr Obes
Yang Q, Qin C, Lang Y, Yang W, Yang F, Yang J, Liu K, Yuan J, Zou Y, Liu F.   +9 more
europepmc   +1 more source

The Early Pathogenesis of Diabetic Retinopathy and Its Attenuation by Sodium-Glucose Transporter 2 Inhibitors. [PDF]

Diabetes
Yamato M, Kato N, Yamada KI, Inoguchi T.
europepmc   +1 more source